´« ¹è·Á Blog

Á¦ÇѵǴ ¼¼°èÀûÀÎ »ý¹° nanotech ȸ»ç pSivida (NASDAQ: PSDV) (ASX: PSD) (Xetra: PSI´Â ½ºÅ×·ÎÀÌµå °ü·Ã ¿Ã·ÁÁø ¾È³» ¾Ð·Â (IOP)¸¦ À§ÇÑ Á¡¾È¾× 󸮷Î) ¿À´Ã MifepristoneÀÇ ´Ü°è II ÀÓ»ó ½ÃÇèÀÇ °³½Ã¸¦ (RU486·Î ±×·¸Áö ¾ÊÀ¸¸é ¾Ë°í ÀÖ) ¾Ë·È´Ù.

Á¶»çÀÚ ÈÄ¿øÇÑ ¿¹½ÉÀº ¹Ì±¹¿¡ ÀÖ´Â 45¸í±îÁö ȯÀÚ¸¦ Æ÷ÇÔÇÒ °ÍÀÌ´Ù. pSivida´Â ÀÌ Çй®À» À§ÇÑ ÀÓ»ó ½ÃÇè ¹°ÀÚ¸¦ °ø±ÞÇÏ°í ±×¸®°í ÀÌ Á¦Ç° Á¾·ù¿¡ ƯÇã ½ÅûÀ» ½ÅûÇß´Ù.

³ôÀº IOP´Â ¸¸¼º ´« Áúº´À» À§ÇÑ steroidal 󸮸¦ ¹Þ¾Æ ȯÀÚ¿¡¼­ »ý±æÁöµµ ¸ð¸¥´Ù. ¿¹½ÉÀºÀ¸·Î MifepristoneÀÇ »ç¿ëÀ» ¾È³» ½ºÅ×·ÎÀÌµå ³ëÃâ¿¡¼­ IOPÀÇ °í°¢À» ¹æÁöÇÏ´Â ¹æ¹ý Á¶»çÇÒ °ÍÀÌ´Ù. Mifepristone´Â ÀÌ¹Ì FDA¿¡ ÀÇÇØ Âù¼ºµÈ ½ºÅ×·ÎÀÌµå ¼ö¿ëü ±æÇ×±Ù ("½ºÅ×·ÎÀ̵å Â÷´ÜÁ¦")ÀÌ´Ù. ÀÌ Çй®Àº »õ·Î¿î Àü´Þ°è¿¡ ÀÇÇØ °¡´ÉÇÏ°Ô ÇÑ ±âÁ¸ÇÏ´Â ¾àÀÇ ÀáÀçÀûÀÎ »õ·Î¿î »ç¿ëÀ» ´ëÇ¥ÇÑ´Ù.

¿¬°á

¹Ø¿¡ ½ÅûÇÏ´Â Eye Treatment |

´ç½ÅÀº ¶ÇÇÑ ÀÐ°í ½ÍÀ»Áöµµ ¸ð¸¥´Ù

• Lumigan ÀÇ AllerganÀÇ ¾È³» ¾Ð·Â ¾à, ÁÖ¾îÁø FDA ½ÂÀÎ
• Alcon´Â Travatan-Z¸¦ À§ÇÑ FDA ½ÂÀÎÀ» ¾ò´Â´Ù ³ôÀº ¾È³» ¾Ð·ÂÀ» °¨¼Ò½ÃÅ°´Â
• ´« ¿°ÁõÀ» À§ÇÑ Á¶ÇÕ Ç×»ýÁ¦ ½ºÅ×·ÎÀ̵å´Â FDA ½ÂÀÎÀ» À§ÇØ ½ÅûÇß´Ù
• Macular Á¥´Â Age-Related Å𺸸¦ À§ÇÑ ¾à EvizonÀÇ ´Ü°è II ÀÓ»ó ½ÃÇè
• ´Ü°è III ¿¹½É¿¡¼­ ¼º°ø º½ °¢°á¸·¿° (VKC)¸¦ À§ÇÑ Novagali ´« ó¸®
• ÇÒ ¼ö ÀÖÀ¸½Ê½Ã¿À Fite ½ÃÀÛÇÑ´Ù °¢¸·¿° Sicca (°ÇÁ¶ÇÏ ´« ÁõÈıº)ÀÇ ÁõÈÄÀÇ Ã³¸®¸¦ À§ÇÑ ´Ü°è II ¿¹½ÉÀ»
• Àüµµ¼º °¢¸· À̽ÄÀº (ºñ Laser ±¼Àý ÀýÂ÷) µ§¹ö¿Í ÄÝ·Î¶óµµ ½ºÇÁ¸µ½º¿¡¼­ µ¥ºßÇÑ´Ù
• Antibiotic Doxycycline Successfully Treats Eye Lymphoma
• Lucentis - Wet Macular Degeneration Drug is Highly Successful in Clinical Trials
• Brand New Treatment For Macular Degeneration

This entry was posted on Wednesday, September 27th, 2006 at 10:13 am. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.